537 related articles for article (PubMed ID: 25525179)
21. Microbiota and prebiotics modulation of uremic toxin generation.
Koppe L; Fouque D
Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
[TBL] [Abstract][Full Text] [Related]
22. Lubiprostone for treatment-resistant constipation associated with clozapine use.
Meyer JM; Cummings MA
Acta Psychiatr Scand; 2014 Jul; 130(1):71-2. PubMed ID: 24912951
[No Abstract] [Full Text] [Related]
23. Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by
Tungsanga S; Panpetch W; Bhunyakarnjanarat T; Udompornpitak K; Katavetin P; Chancharoenthana W; Chatthanathon P; Somboonna N; Tungsanga K; Tumwasorn S; Leelahavanichkul A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269654
[TBL] [Abstract][Full Text] [Related]
24. Lubiprostone: a chloride channel activator.
Lacy BE; Levy LC
J Clin Gastroenterol; 2007 Apr; 41(4):345-51. PubMed ID: 17413599
[TBL] [Abstract][Full Text] [Related]
25. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141
[TBL] [Abstract][Full Text] [Related]
26. Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
Kikuchi M; Ueno M; Itoh Y; Suda W; Hattori M
Nephron; 2017; 135(1):51-60. PubMed ID: 27701177
[TBL] [Abstract][Full Text] [Related]
27. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
[TBL] [Abstract][Full Text] [Related]
28. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.
Vitetta L; Gobe G
Mol Nutr Food Res; 2013 May; 57(5):824-32. PubMed ID: 23450842
[TBL] [Abstract][Full Text] [Related]
29. Gut-Derived Protein-Bound Uremic Toxins.
Graboski AL; Redinbo MR
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
[TBL] [Abstract][Full Text] [Related]
30. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.
Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730
[TBL] [Abstract][Full Text] [Related]
31. Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
Kato T; Honda Y; Kurita Y; Iwasaki A; Sato T; Kessoku T; Uchiyama S; Ogawa Y; Ohkubo H; Higurashi T; Yamanaka T; Usuda H; Wada K; Nakajima A
PLoS One; 2017; 12(4):e0175626. PubMed ID: 28410406
[TBL] [Abstract][Full Text] [Related]
32. Pharmaceutical Activation or Genetic Absence of ClC-2 Alters Tight Junctions During Experimental Colitis.
Jin Y; Pridgen TA; Blikslager AT
Inflamm Bowel Dis; 2015 Dec; 21(12):2747-57. PubMed ID: 26332307
[TBL] [Abstract][Full Text] [Related]
33. Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.
Bijvelds MJ; Bot AG; Escher JC; De Jonge HR
Gastroenterology; 2009 Sep; 137(3):976-85. PubMed ID: 19454284
[TBL] [Abstract][Full Text] [Related]
34. Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet.
Ikee R; Sasaki N; Yasuda T; Fukazawa S
Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33255763
[TBL] [Abstract][Full Text] [Related]
35. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
[TBL] [Abstract][Full Text] [Related]
36. The gut-kidney axis.
Evenepoel P; Poesen R; Meijers B
Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
[TBL] [Abstract][Full Text] [Related]
37. Contribution of uremic dysbiosis to insulin resistance and sarcopenia.
Uchiyama K; Wakino S; Irie J; Miyamoto J; Matsui A; Tajima T; Itoh T; Oshima Y; Yoshifuji A; Kimura I; Itoh H
Nephrol Dial Transplant; 2020 Sep; 35(9):1501-1517. PubMed ID: 32535631
[TBL] [Abstract][Full Text] [Related]
38. The Association between Gut Microbiota and Uremia of Chronic Kidney Disease.
Kim JE; Kim HE; Park JI; Cho H; Kwak MJ; Kim BY; Yang SH; Lee JP; Kim DK; Joo KW; Kim YS; Kim BS; Lee H
Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32560104
[TBL] [Abstract][Full Text] [Related]
39. SGLT-1-specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine-induced renal failure.
Ho HJ; Kikuchi K; Oikawa D; Watanabe S; Kanemitsu Y; Saigusa D; Kujirai R; Ikeda-Ohtsubo W; Ichijo M; Akiyama Y; Aoki Y; Mishima E; Ogata Y; Oikawa Y; Matsuhashi T; Toyohara T; Suzuki C; Suzuki T; Mano N; Kagawa Y; Owada Y; Katayama T; Nakayama T; Tomioka Y; Abe T
Physiol Rep; 2021 Dec; 9(24):e15092. PubMed ID: 34921520
[TBL] [Abstract][Full Text] [Related]
40. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone.
Moeser AJ; Nighot PK; Engelke KJ; Ueno R; Blikslager AT
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G647-56. PubMed ID: 17053162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
